While there's still no cure for the disease, Thayer notes in a companion article in C&EN, researchers are working hard to develop an effective HIV vaccine, considered the ultimate way to prevent infection. But there's still a lot to learn about the virus itself and the human body's response, as setbacks in recent clinical trials have shown, according to the article. "Failure is the norm in product development, particularly for something as difficult as HIV," notes one researcher.
ARTICLE #5 EMBARGOED FOR 9 A.M., EASTERN TIME, Sept. 22, 2008
"New Antiretrovirals Change HIV Treatment"
This story will be available on Sept. 22 at
FOR ADVANCE INFORMATION, CONTACT:
ACS News Service
Press releases, chat room sessions, and more from ACS' 236th National Meeting
It's never too late to explore a treasure trove of news sources, background material and story ideas available from the ACS' latest National Meeting, which was held in Philadelphia in August. Reporters can view press releases, search an archive with abstracts of more than 9,000 scientific presentations and hundreds of non-technical summaries of those presentations, and access other resources at: www.eurekalert.org/acsmeet.php.
The ACS Office of Public Affairs also offers recorded video versions of its national meeting "chat room" briefings and accompanying chat transcripts by going to
|Contact: Michael Bernstein|
American Chemical Society